Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble

About this trial

In the context of a bacteremia, although significant progress has been made in speeding up pathogen identification once a blood culture bottle turns positive, few cost-effective solutions have been proposed to improve the earlier stages of the process-specifically, from blood collection to bottle positivity. The investigators propose that transport time could be leveraged to grow and identify bacteria, enabling faster access to actionable results through innovative technologies. This project aims to develop a bacterial identification database by analyzing the electrochemical profile of bacteria growing within the blood culture bottle, using machine learning.

Eligibility criteria

Qualifiers

patient requiring a blood culture sample as standard of care procedure

body weight > 50 Kg

Patient for whom the collection of 2 to 4 additional blood culture bottles is feasible, depending on venous access

patient who has not objected to participation in the project

Disqualifiers

Patient protected under the French Public Health Code (pregnant or breastfeeding women, patients under guardianship or curatorship, hospitalized under constraint, or deprived of liberty)

patients with ongoing antibiotic treatment at the time of sampling

Trial design

Treatments tested in this trial

  • Blood culture sampling

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators